{"version":"1.0","provider_name":"Division of Infectious Diseases","provider_url":"https:\/\/blog.unmc.edu\/infectious-disease","author_name":"Kelly Cawcutt","author_url":"https:\/\/blog.unmc.edu\/infectious-disease\/author\/298f95e1bf9136124592c8d4825a06fc\/","title":"Resistant CMV - Research Aimed at the Cure - Division of Infectious Diseases","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"qHfKqYrvmB\"><a href=\"https:\/\/blog.unmc.edu\/infectious-disease\/2017\/10\/05\/395\/\">Resistant CMV &#8211; Research Aimed at the Cure<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/blog.unmc.edu\/infectious-disease\/2017\/10\/05\/395\/embed\/#?secret=qHfKqYrvmB\" width=\"600\" height=\"338\" title=\"&#8220;Resistant CMV &#8211; Research Aimed at the Cure&#8221; &#8212; Division of Infectious Diseases\" data-secret=\"qHfKqYrvmB\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/blog.unmc.edu\/infectious-disease\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/blog.unmc.edu\/infectious-disease\/wp-content\/uploads\/sites\/54\/2017\/09\/CMV2.jpg","thumbnail_width":700,"thumbnail_height":472,"description":"&nbsp; Infections due to Cytomegalovirus(CMV) remain a significant problem for patients undergoing various types of transplants, including both hematopoietic stem cell transplants and solid organ transplant, particularly since these groups both require the use of potent immunosuppressive chemotherapy. Although the currently available systemic anti-cytomegalovirus agents are usually effective, their use is limited by their toxicities, [&hellip;]"}